4-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide
C25H27N5OS — CID 134329728
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide
4-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide (PubChem CID 134329728) has the molecular formula C25H27N5OS and a molecular weight of 445.59 g/mol. Its IUPAC name is 4-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 4-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide |
|---|---|
| PubChem CID | 134329728 |
| Molecular Formula | C25H27N5OS |
| Molecular Weight | 445.59 g/mol |
| Exact Mass | 445.19 |
| IUPAC Name | 4-(5-piperidin-4-yl-3-propan-2-yl-1H-indol-2-yl)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide |
| SMILES | CC(C)c1c(-c2ccnc(C(=O)Nc3nccs3)c2)[nH]c2ccc(C3CCNCC3)cc12 |
| InChI | InChI=1S/C25H27N5OS/c1-15(2)22-19-13-17(16-5-8-26-9-6-16)3-4-20(19)29-23(22)18-7-10-27-21(14-18)24(31)30-25-28-11-12-32-25/h3-4,7,10-16,26,29H,5-6,8-9H2,1-2H3,(H,28,30,31) |
| InChIKey | CCJMOSBGVWZGMG-UHFFFAOYSA-N |
| XLogP | 5.53 |
| TPSA | 82.70 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.59 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134329728 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.